TAMPERE, Finland: The long-standing relationship between oral bacteria and systemic disease has taken on new significance with recent advances in molecular medicine. As part of
The U.S. Food and Drug Administration (FDA) is strengthening an existing label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart